157 related articles for article (PubMed ID: 6584235)
1. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
2. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
5. Distribution, excretion, and metabolism of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea (ACNU) in rats and mice after iv administration.
Tanaka M; Nishigaki T; Nakajima E; Totsuka S; Nakamura K
Cancer Treat Rep; 1980; 64(4-5):575-80. PubMed ID: 6933003
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
Yoshida J; Shibuya N; Kobayashi T; Kageyama N
Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
8. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
[TBL] [Abstract][Full Text] [Related]
9. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
10. Effect of 1(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) on Sato lung carcinoma (SLC). Preliminary result of immunochemotherapy for SLC by combination of ACNU and Propionibacterium acnes.
Saijo N; Niitani H; Irimajiri N; Chikama M
Oncology; 1979; 36(1):7-10. PubMed ID: 450390
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
Shimizu F; Arakawa M
Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
[TBL] [Abstract][Full Text] [Related]
13. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
Fujimoto S; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
[TBL] [Abstract][Full Text] [Related]
14. Interaction of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride with nucleic acids and proteins.
Nishigaki T; Tanaka M
Chem Biol Interact; 1985 Dec; 56(2-3):213-24. PubMed ID: 2416482
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.
Edanami K; Komiyama K; Kuroda T; Umezawa I
Cancer Chemother Pharmacol; 1984; 13(1):22-6. PubMed ID: 6234104
[TBL] [Abstract][Full Text] [Related]
16. Identification of major urinary metabolites of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride in rats.
Nishigaki T; Nakamura K; Kinoshita T; Kuwano H; Tanaka M
J Pharmacobiodyn; 1985 Jun; 8(6):401-8. PubMed ID: 3863921
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3- nitrosoureahydrochloride and three related N-nitroso derivatives following repeated intravenous administration to male Wistar rats.
Berger MR; Petru E; Schmähl D
Oncology; 1988; 45(2):127-33. PubMed ID: 3162572
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined treatment with nimustine hydrochloride and radiation on solid FM3A tumor in mice.
Shimizu F; Inomata T; Mizuno H; Arakawa M; Ogata T; Okawa T
Jpn J Cancer Res; 1987 Jul; 78(7):756-62. PubMed ID: 3114202
[TBL] [Abstract][Full Text] [Related]
20. [Effects of phenobarbital on the metabolism of ACNU in vivo].
Nagashima T; Matsutani M; Kohono T
No To Shinkei; 1983 Jul; 35(7):677-82. PubMed ID: 6578801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
